Status:
COMPLETED
Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy
Lead Sponsor:
Universidad Complutense de Madrid
Conditions:
Xerosis Cutis
Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluation of cannabidiol and urea 10%.
Detailed Description
This study evaluated the impact of cannabidiol on neuropathic pain and the action of urea 10% on skin quality in patients with diabetic foot syndrome and diabetic neuropathy.
Eligibility Criteria
Inclusion
- Patients all biological sexes
- Patients of legal age (18 years).
- Patients without cognitive impairment
- Patients Diagnosed with diabetic neuropathy,
- Patients who were able to complete the neuropathic pain scale autonomously, cooperatively and independently.
Exclusion
- Patients who declined participation
- Patients with critical ischaemia and
- Patients with a history of allergy or hypersensitivity to any of the components of the cream were excluded from the study.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT07162454
Start Date
November 1 2024
End Date
June 30 2025
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultad de Enfermería, Fisioterapia y Podología de la Universidad Complutense de Madrid
Madrid, Spain, 28040